Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-29 5:05 pm Purchase | 13D | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 6,373,676 14.4% | 350,000 (+5.81%) | View |
2024-03-18 7:46 pm Purchase | 13D | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 6,023,676 13.7% | 607,560 (+11.22%) | View |
2024-02-14 4:02 pm Sale | 13G | CARDLYTICS INC CDLX | 683 Capital Management LLC | 1,758,462 4.6% | -124,558 (-6.61%) | View |
2024-02-13 5:00 pm Sale | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,153,790 5.49% | -238,967 (-9.99%) | View |
2024-01-26 11:50 am Purchase | 13G | CARDLYTICS INC CDLX | BlackRock Inc. BLK | 2,912,025 7.4% | 187,540 (+6.88%) | View |
2023-09-19 4:30 pm Unchanged | 13D | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 5,416,116 14.4% | 0 (Unchanged) | View |
2023-06-23 4:20 pm Unchanged | 13D | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 5,416,116 16% | 0 (Unchanged) | View |
2023-02-14 5:40 pm Sale | 13G | CARDLYTICS INC CDLX | 683 Capital Management LLC | 1,883,020 5.7% | -293,639 (-13.49%) | View |
2023-02-14 11:44 am Purchase | 13G | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 5,416,116 16.3% | 229,650 (+4.43%) | View |
2023-02-09 11:12 am Sale | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,392,757 7.21% | -512,285 (-17.63%) | View |
2023-02-07 4:04 pm Purchase | 13G | CARDLYTICS INC CDLX | BlackRock Inc. BLK | 2,724,485 8.2% | 329,872 (+13.78%) | View |
2022-12-09 1:50 pm Sale | 13G | CARDLYTICS INC CDLX | WELLINGTON MANAGEMENT GROUP LLP | 18,531 0.06% | -1,932,876 (-99.05%) | View |
2022-09-09 10:26 am Sale | 13G | CARDLYTICS INC CDLX | WELLINGTON MANAGEMENT GROUP LLP | 1,951,407 5.93% | -1,902,608 (-49.37%) | View |
2022-07-21 3:08 pm Purchase | 13G | CARDLYTICS INC CDLX | 683 Capital Management LLC | 2,176,659 6.4% | 2,176,659 (New Position) | View |
2022-06-03 1:48 pm Sale | 13G | CARDLYTICS INC CDLX | JPMORGAN CHASE & CO JPM | 153,697 0.4% | -1,908,411 (-92.55%) | View |
2022-02-11 5:32 pm Purchase | 13G | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 5,186,466 15.6% | 697,494 (+15.54%) | View |
2022-02-09 3:33 pm Purchase | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,905,042 8.73% | 1,068,299 (+58.16%) | View |
2022-02-04 09:15 am Purchase | 13G | CARDLYTICS INC CDLX | WELLINGTON MANAGEMENT GROUP LLP | 3,854,015 11.58% | 87,775 (+2.33%) | View |
2022-02-03 4:29 pm Purchase | 13G | CARDLYTICS INC CDLX | BlackRock Inc. BLK | 2,394,613 7.2% | 345,746 (+16.87%) | View |
2022-01-07 3:41 pm Purchase | 13G | CARDLYTICS INC CDLX | JPMORGAN CHASE & CO JPM | 2,062,108 6.1% | 681,245 (+49.33%) | View |